CURRENT OPINION IN RHEUMATOLOGY

Scope & Guideline

Empowering Professionals with Insightful Analyses

Introduction

Welcome to your portal for understanding CURRENT OPINION IN RHEUMATOLOGY, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1040-8711
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1989 to 2024
AbbreviationCURR OPIN RHEUMATOL / Curr. Opin. Rheumatol.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

CURRENT OPINION IN RHEUMATOLOGY serves as a premier platform for disseminating the latest insights and research findings in the field of rheumatology. The journal focuses on a wide array of topics related to the pathogenesis, diagnosis, and management of rheumatic diseases, emphasizing innovative therapeutic strategies and the integration of new technologies in clinical practice.
  1. Pediatric Rheumatology:
    The journal highlights advancements in the understanding and management of rheumatic diseases in children, focusing on conditions such as juvenile idiopathic arthritis and systemic lupus erythematosus.
  2. Biologic and Targeted Therapies:
    A core area of focus is the exploration of novel biologic agents and targeted therapies for various rheumatic conditions, emphasizing their mechanisms of action, efficacy, and safety.
  3. Pathogenesis and Mechanistic Insights:
    Research on the underlying mechanisms of rheumatic diseases, including cellular and molecular pathways, is a significant focus, enabling the identification of new therapeutic targets.
  4. Clinical Guidelines and Management Strategies:
    The journal regularly publishes updates on clinical guidelines and consensus statements, providing practitioners with evidence-based approaches to managing complex rheumatic conditions.
  5. Emerging Technologies in Rheumatology:
    There is a growing emphasis on the application of artificial intelligence, machine learning, and advanced imaging techniques to enhance diagnosis, treatment, and patient care in rheumatology.
  6. Health Disparities and Patient-Centered Care:
    The journal addresses health disparities in rheumatic diseases, focusing on the social determinants of health and the need for equitable care across diverse populations.
The landscape of rheumatology is constantly changing, and CURRENT OPINION IN RHEUMATOLOGY reflects this dynamism through its focus on emerging themes and trends that shape the future of research and clinical practice.
  1. Personalized Medicine:
    A significant trend is the increasing interest in personalized medicine approaches, particularly in the context of systemic lupus erythematosus and systemic sclerosis, where tailored therapies based on genetic and immunological profiling are being explored.
  2. Artificial Intelligence and Machine Learning:
    The integration of artificial intelligence and machine learning in rheumatology is gaining traction, with studies focusing on their potential to improve diagnosis, predict disease flares, and optimize treatment strategies.
  3. Microbiome Research:
    Emerging studies are investigating the role of the microbiome in rheumatic diseases, exploring how microbiota composition may influence disease pathogenesis and treatment responses.
  4. Health Equity and Disparities:
    There is an increasing focus on health equity, addressing disparities in access to care and outcomes for diverse populations affected by rheumatic diseases.
  5. Innovations in Pediatric Rheumatology:
    Recent publications indicate a growing emphasis on advancements in the understanding and management of pediatric rheumatic diseases, highlighting unique therapeutic needs and challenges.

Declining or Waning

While CURRENT OPINION IN RHEUMATOLOGY continues to evolve, certain themes have shown a decline in prominence over recent years. These waning areas suggest a shift in focus towards more contemporary issues and innovative approaches within the field.
  1. Traditional Pharmacotherapy:
    The emphasis on conventional pharmacotherapy, including nonsteroidal anti-inflammatory drugs (NSAIDs) and glucocorticoids, has decreased as newer biologic and targeted therapies gain prominence.
  2. Basic Science Research:
    The journal appears to be moving away from purely basic science studies, favoring clinical applications and translational research that have immediate relevance to patient care.
  3. Generalized Clinical Reviews:
    There is a noticeable reduction in the publication of broad clinical review articles in favor of more targeted studies that address specific conditions or innovative therapies.

Similar Journals

Archives of Rheumatology

Advancing knowledge in rheumatology for a healthier future.
Publisher: TURKISH LEAGUE AGAINST RHEUMATISMISSN: Frequency: 4 issues/year

Archives of Rheumatology is a premier peer-reviewed journal dedicated to advancing the field of rheumatology through the dissemination of high-quality research, reviews, and case studies. Published by the Turkish League Against Rheumatism, this open-access journal provides a platform for researchers, clinicians, and students to share insightful findings and innovative approaches in the diagnosis and management of rheumatologic diseases. With the goal of promoting knowledge exchange on a global scale, the journal welcomes submissions that enhance understanding and foster advancements in the clinical and biological aspects of rheumatic conditions. Each publication contributes significantly to the growing body of literature in this vital field of medicine, making Archives of Rheumatology an essential resource for both established and emerging researchers looking to stay abreast of the latest developments and clinical practices.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY

Fostering innovation for better patient outcomes.
Publisher: CLINICAL & EXPER RHEUMATOLOGYISSN: 0392-856XFrequency: 6 issues/year

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.

RMD Open

Transforming patient care through innovative research.
Publisher: BMJ PUBLISHING GROUPISSN: 2056-5933Frequency: 2 issues/year

RMD Open, published by the BMJ Publishing Group, is a leading open-access journal that has made significant contributions to the fields of Immunology, Immunology and Allergy, and Rheumatology since its inception in 2015. With an impressive Q1 ranking in these categories for 2023, the journal has established itself as an essential platform for the dissemination of high-quality research, case studies, and reviews that advance understanding and treatment strategies in these critical areas of health. As an open-access publication, RMD Open ensures that its content is freely accessible to a global audience, promoting collaboration and knowledge sharing among researchers, clinicians, and students. Based in the United Kingdom at the British Medical Association House, RMD Open is not only dedicated to improving patient care but also to fostering innovative research and discussions in the rapidly evolving landscape of rheumatic diseases.

Indian Journal of Rheumatology

Exploring the frontiers of rheumatologic care and research.
Publisher: SAGE PUBLICATIONS INCISSN: 0973-3698Frequency: 4 issues/year

Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.

Modern Rheumatology

Exploring Breakthroughs in Rheumatic Disease Research
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY

Driving Excellence in Rheumatology Scholarship
Publisher: TAYLOR & FRANCIS LTDISSN: 0300-9742Frequency: 6 issues/year

The Scandinavian Journal of Rheumatology, published by Taylor & Francis Ltd, is a prestigious peer-reviewed journal dedicated to advancing research in the fields of rheumatology, immunology, and related disciplines. With an ISSN of 0300-9742 and an E-ISSN of 1502-7732, this journal has established itself as a vital platform for disseminating significant findings and innovative approaches in the management of rheumatic diseases since its inception in 1959. As a recognized scholarly outlet, it currently resides within the Q2 category for Medicine (miscellaneous) and ranks #39 out of 73 in Rheumatology according to the 2023 Scopus assessments. This reflects the journal's commitment to high-quality research and its relevance in the scientific community. Although it does not provide Open Access options, the journal's rigorous selection process ensures that only the most impactful research reaches its audience, making it a crucial resource for researchers, clinicians, and students engaged in the exploration of rheumatological and immunological challenges. The journal's broad scope encompasses ongoing studies, clinical trials, and reviews that aim to enhance understanding and treatment of rheumatic conditions, promoting collaboration and knowledge-sharing among professionals in the field.

Current Rheumatology Reviews

Shaping the future of rheumatology through rigorous reviews.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3971Frequency: 3 issues/year

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

Reumatismo

Elevating understanding of rheumatic conditions through open access.
Publisher: PAGEPRESS PUBLISSN: 0048-7449Frequency: 4 issues/year

Reumatismo is a distinguished Open Access journal dedicated to the field of rheumatology, published by PAGEPRESS PUBL since 2001. With a rich history dating back to 1952, this journal has been pivotal in disseminating vital research on rheumatic diseases and related disorders. Based in Italy, Reumatismo has earned a reputation for its quality and relevance, achieving a Q3 category ranking in the 2023 Scopus metrics for Rheumatology, reflecting its significant contributions to the field. The journal is committed to providing a platform for the latest scientific developments and clinical innovations, thus aiding researchers, healthcare professionals, and students striving to enhance understanding and treatment of rheumatic conditions. For those seeking to access comprehensive research articles and studies, Reumatismo boasts an open access policy, ensuring that knowledge is freely available to all, fostering collaboration and advancement in rheumatology worldwide.

Lupus Science & Medicine

Empowering knowledge to combat lupus effectively.
Publisher: BMJ PUBLISHING GROUPISSN: 2053-8790Frequency: 1 issue/year

Lupus Science & Medicine is a leading open-access journal published by the BMJ Publishing Group, dedicated to advancing the understanding and treatment of lupus and related autoimmune diseases. Since its establishment in 2014, the journal has fostered an academic environment for researchers, healthcare professionals, and students, providing a platform for high-quality, evidence-based studies. With a notable impact in the fields of immunology and rheumatology, it currently holds a Q1 ranking in Rheumatology and Medicine (miscellaneous) and Q2 in Immunology, reflecting its significant contribution to these vital areas of medical research. The journal is indexed in Scopus, with a commendable rank in the 67th percentile for Rheumatology, making it a valuable resource for those seeking the latest insights into lupus management and treatment. The journal emphasizes the importance of open access, ensuring that research findings are widely available to enhance global knowledge and collaboration in the fight against lupus.

Advances in Rheumatology

Unlocking the potential of rheumatology through open access.
Publisher: BMCISSN: 2523-3106Frequency: 1 issue/year

Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.